Stockscreener 앱 받기
1.70
11.14%
0.135
전일 마감가:
$1.565
열려 있는:
$1.69
하루 거래량:
32.67M
Relative Volume:
51.01
시가총액:
$39.90M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+28.84%
1개월 성능:
+46.16%
6개월 성능:
-4.43%
1년 성능:
+0.00%
1일 변동 폭
$1.57
$1.76
1주일 범위
$1.30
$1.76
52주 변동 폭
$1.04
$3.50
Rein Therapeutics Inc Stock (RNTX) Company Profile
명칭
Rein Therapeutics Inc
전화
(737) 802-1989
주소
12407 N. MOPAC EXPY., AUSTIN
RNTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RNTX
Rein Therapeutics Inc
|
1.712 | 37.60M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.74 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.57 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.54 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.40 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.00 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rein Therapeutics Inc Stock (RNTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-22 | 개시 | H.C. Wainwright | Buy |
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2017-07-24 | 개시 | BofA/Merrill | Buy |
| 2017-07-24 | 개시 | Jefferies | Buy |
| 2017-07-24 | 개시 | William Blair | Outperform |
Rein Therapeutics Inc 주식(RNTX)의 최신 뉴스
Rein Therapeutics Receives FDA Clearance to Resume Phase 2 Trial - TradingView
Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis - The Manila Times
How Rein Therapeutics Inc. stock reacts to bond yieldsJuly 2025 Setups & Daily Volume Surge Trade Alerts - newser.com
Ranking Rein Therapeutics Inc. among high performing stocks via toolsQuarterly Investment Review & Weekly Hot Stock Watchlists - newser.com
Technical signs of recovery in Rein Therapeutics Inc.July 2025 Catalysts & Community Consensus Stock Picks - newser.com
Multi asset correlation models including Rein Therapeutics Inc.Weekly Trend Summary & Daily Growth Stock Tips - newser.com
Why Rein Therapeutics Inc. stock attracts high net worth investorsTrade Analysis Summary & Weekly High Return Stock Opportunities - newser.com
News impact scoring models applied to Rein Therapeutics Inc.Weekly Trade Recap & Risk Controlled Swing Trade Alerts - newser.com
Price momentum metrics for Rein Therapeutics Inc. explainedEarnings Recap Report & Technical Analysis for Trade Confirmation - newser.com
Will Rein Therapeutics Inc. stock reach Wall Street targetsJuly 2025 Update & Short-Term Trading Opportunity Alerts - newser.com
Using economic indicators to assess Rein Therapeutics Inc. potential2025 AllTime Highs & Detailed Earnings Play Strategies - newser.com
Why retail investors pile into Rein Therapeutics Inc. stock2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - newser.com
Rein Therapeutics Inc. stock retracement – recovery analysis2025 Geopolitical Influence & AI Driven Price Predictions - newser.com
Rein Therapeutics Inc. Stock (RNTX) Opinions on Institutional Investments and Funding Deals - Quiver Quantitative
Is Rein Therapeutics Inc. stock a defensive play in 20252025 Market WrapUp & AI Based Trade Execution Alerts - fcp.pa.gov.br
How rising interest rates impact Rein Therapeutics Inc. stock2025 Growth vs Value & AI Driven Stock Reports - fcp.pa.gov.br
VIX Spike: How rising interest rates impact Rein Therapeutics Inc. stockBond Market & Real-Time Volume Analysis Alerts - fcp.pa.gov.br
Applying sector rotation models to Rein Therapeutics Inc.2025 Price Action Summary & Weekly Consistent Profit Watchlists - newser.com
Rein Therapeutics Inc (RNTX) 재무 분석
Rein Therapeutics Inc (RNTX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Rein Therapeutics Inc 주식 (RNTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Voss Capital, LP | 10% Owner |
Oct 27 '25 |
Buy |
1.37 |
97,482 |
133,544 |
822,258 |
| Voss Capital, LP | 10% Owner |
Oct 24 '25 |
Buy |
1.39 |
30,176 |
41,957 |
729,616 |
| WINDSOR JAMES BRIAN | President and CEO |
Dec 05 '24 |
Buy |
2.24 |
400 |
898 |
239 |
0.03%
0.32%
자본화:
|
볼륨(24시간):